Provided by Tiger Trade Technology Pte. Ltd.

CVS Health

85.69
-1.4100-1.62%
Post-market: 85.930.2400+0.28%19:52 EDT
Volume:8.38M
Turnover:720.85M
Market Cap:109.82B
PE:22.45
High:87.44
Open:87.04
Low:85.42
Close:87.10
52wk High:110.68
52wk Low:69.51
Shares:1.28B
Float Shares:1.27B
Volume Ratio:0.92
T/O Rate:0.66%
Dividend:2.66
Dividend Rate:3.10%
EPS(TTM):3.82
EPS(LYR):1.39
ROE:6.21%
ROA:2.97%
PB:1.38
PE(LYR):61.65

Loading ...

CVS Climbs After Raising Annual Profit Forecast

Reuters
·
Aug 05

CVS Health Raises Earnings Outlook and Launches Lilly Partnership. the Stock Jumps.

Dow Jones
·
Aug 05

CVS Health Q2 Revenue Beats Estimates, Outlook Raised

Reuters
·
Aug 05

CVS Q2 FY26 GAAP EPS More than Doubled to $2.31; Revenue Rises 7.3% to $106.1 Billion

Reuters
·
Aug 05

Stock Track | CVS Health Soars 5.33% in Pre-market on Strong Q2 Earnings Beat, Raised Guidance, and GLP-1 Strategy Expansion

Stock Track
·
Aug 05

GUIDANCE: (CVS) CVS Health Expects 2026 Adjusted EPS Range $7.90 to $8.10, vs. FactSet Est of $7.45

MT Newswires Live
·
Aug 05

CVS Health Shares up 4.5% Premarket After Co Forecasts 2026 Revenue Above Estimates

THOMSON REUTERS
·
Aug 05

Movement Alert|CVS Health Rises 3.81% in Pre-Market Trading, Earnings Day Coupled with Comprehensive GLP-1 Strategy Upgrade

Market Focus
·
Aug 05

CVS Health Q2 Adj. EPS $2.58 Beats $1.85 Estimate, Sales $106.096B Beat $100.114B Estimate

Benzinga Earnings
·
Aug 05

CVS Q2 Adjusted EPS USD 2.58 Vs. IBES Estimate USD 1.85

Reuters
·
Aug 05

Cvs Q2 EPS Usd 2.31

THOMSON REUTERS
·
Aug 05

CVS Q2 Revenue USD 106,100 Million VS. Ibes Estimate USD 100,114 Million

THOMSON REUTERS
·
Aug 05

CVS Outlook FY Adj EPS $7.90 to $8.10 VS. Ibes Estimate $7.45

THOMSON REUTERS
·
Aug 05

CVS: to Offer $29 Minuteclinic Virtual Visits for Patients Seeking Glp-1 Medications

THOMSON REUTERS
·
Aug 05

CVS Outlook FY Cash Flow from Operations to at Least $11.5 Bln

THOMSON REUTERS
·
Aug 05

CVS: Maintaining Cautious View for Remainder of Year in Light of Continued Elevated Cost Trends, Potential for Macro Headwinds

THOMSON REUTERS
·
Aug 05

CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as 2Q Profit Increases

Dow Jones
·
Aug 05

CVS Q2 Medical Benefit Ratio at 87.4% vs Ibes Estimate 90.03%

THOMSON REUTERS
·
Aug 05

CVS Health Corporation -CVS Pharmacy Offers All FDA Approved Glp-1 Medications Via Insurance or Cash-Pay Options

THOMSON REUTERS
·
Aug 05

CVS Health Corp: Co & Lilly Collaborating to Help Eligible Zepbound and Foundayo Patients More Easily Access Transparent Pricing

THOMSON REUTERS
·
Aug 05